Exploring the US FDA's Upcoming Complex Generic Product-Specific Guidance Lists
Executive Summary
The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.
You may also be interested in...
GDUFA III: Convening Enhanced Mid-Cycle Meeting Will Cost Sponsors
Requesting the new meeting type for an ANDA assessment will trigger a goal date extension with another possible should an unsolicited application amendment also be necessary.
GDUFA III: Convening Enhanced Mid-Cycle Meeting Will Cost Sponsors
Requesting the new meeting type for an ANDA assessment will trigger a goal date extension with another possible should an unsolicited application amendment also be necessary.
Was Coronavirus A Factor In US FDA Approval Of Proventil HFA First Generic?
The agency said Cipla’s ANDA met all the requirements for approval, but also that there is increased demand for the products.